Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin topical cream for dermatitis
IRCT20220403054394N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in dermatitis comparing Melatonin cream with Placebo cream (2 arms). Primary endpoints: Dermatitis severity, Pruritus and 4 more. Started Jul 2022; status: completed.
02
Drugs
melatonin
03
Conditions
dermatitis
Beyond the preview
Go deeper on IRCT20220403054394N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220403054394N1.